文献速递脑血管病外科神经重症

黄芪甲苷IV对蛛网膜下腔出血实验大鼠模型迟发性脑血管痉挛的保护作用

Protective Effects of Astragaloside IV on Delayed Cerebral Vasospasm in an Experimental Rat Model of Subarachnoid Hemorrhage.
PubMed 文献 · World Neurosurg · 2018-07-04

该研究在大鼠蛛网膜下腔出血(SAH)模型中评估黄芪甲苷IV(AS-IV)对迟发性脑血管痉挛的作用。SAH-AS-IV组每日腹腔注射AS-IV 20 mg/kg共5天,与SAH-DMSO组和SAH组相比,AS-IV显著减轻了基底动脉壁增厚、管腔横截面积减小、TLR4表达上调、NF-κB活化及血浆肿瘤坏死因子-α和白细胞介素-6升高(P < 0.05)。作者认为AS-IV可能通过抑制TLR4/NF-κB介导的炎症信号通路减轻SAH后迟发性脑血管痉挛。

要点

  • SAH大鼠基底动脉出现管壁增厚、管腔横截面积减小及TLR4/NF-κB炎症信号激活。
  • AS-IV 20 mg/kg每日腹腔注射5天可显著减轻SAH诱导的上述血管与炎症改变(P < 0.05)。
  • 作者认为AS-IV可能通过抑制TLR4/NF-κB介导的炎症信号通路减轻迟发性脑血管痉挛。

核心结论

  • 作者认为AS-IV可能通过抑制TLR4/NF-κB介导的炎症信号通路减轻SAH后迟发性脑血管痉挛。

研究设计与样本

  • 研究建立大鼠SAH模型,通过穿刺一侧颈内动脉诱导SAH。
  • 大鼠每日腹腔注射AS-IV(20 mg/kg;SAH-AS-IV组)、0.1%二甲基亚砜(DMSO)(SAH-DMSO组)或生理盐水(SAH组)共5天,另设接受假手术和生理盐水注射的对照组。

主要发现

  • 与对照组相比,SAH-DMSO组和SAH组基底动脉管壁增厚、管腔横截面积减小(提示血管痉挛),基底动脉TLR4表达增加、NF-κB活化增强,血浆肿瘤坏死因子-α和白细胞介素-6水平升高。
  • 给予AS-IV与SAH诱导的上述所有改变的显著减轻相关(P < 0.05)。

关键数值与推荐

  • AS-IV给药方案为20 mg/kg每日腹腔注射,共5天。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Delayed cerebral vasospasm is an important cause of morbidity and mortality in patients with subarachnoid hemorrhage (SAH). This study aimed to assess the effects of Astragaloside IV (AS-IV) on delayed cerebral vasospasm after SAH. METHODS: A rat model of SAH was established by puncturing one side of the internal carotid artery. Then, rats received daily intraperitoneal injections of AS-IV (20 mg/kg; SAH-AS-IV group), 0.1% dimethyl sulfoxide (DMSO) (SAH-DMSO group), or saline (SAH group) for 5 days; an additional control group consisted of rats receiving sham surgery and saline injections. Morphologic characteristics of the basilar artery (BA) were measured from histologic sections stained with hematoxylin and eosin and used as indicators of cerebral vasospasm. Immunohistochemistry was used to detect Toll-like receptor-4 (TLR4) and nuclear factor kappa B (NF-κB) p65 protein levels in the BA. Enzyme-linked immunosorbent assay was used to measure the plasma concentrations of tumor necrosis factor-alpha and interleukin-6. RESULTS: Compared with controls, the SAH-DMSO and SAH groups showed increased wall thickness and reduced luminal cross-sectional area (indicative of vasospasm) and increased TLR4 expression and enhanced NF-κB activation in the BA, as well as elevated plasma levels of tumor necrosis factor-alpha and interleukin-6. Administration of AS-IV was associated with significant attenuation of all the aforementioned changes induced by SAH (P < 0.05). CONCLUSIONS: AS-IV may attenuate delayed cerebral vasospasm after SAH through inhibition of TLR4/NF-κB-mediated inflammatory signaling pathways.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Ma Y, Qiao G, Yin Y, et al. Protective Effects of Astragaloside IV on Delayed Cerebral Vasospasm in an Experimental Rat Model of Subarachnoid Hemorrhage. World Neurosurg. 2018. PMID: 29981464. doi:10.1016/j.wneu.2018.06.212

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。